methylation blood test Options
5 technological inter and intrarun replicates have been assessed for concordance determined by methylation variant pathogenicity (MVP) rating (inside of 0.05) and clustering analysis. The clinical testing cohort (desk S2) consists of peripheral blood DNA samples from 207 topics, referred by medical professionals dependant on specific clinical disc